WASHINGTON--(BUSINESS WIRE)--The inaugural BIO National Venture Conference ended Wednesday, following a successful run of partnering meetings, company presentations, and featured workshops highlighting seed and early stage private biotech companies. The event also included high level clinical panels featuring key opinion leaders in hot topic fields such as regenerative medicine, antibiotics and RNAi. Hosted by the Biotechnology Industry Organization (BIO), the conference was held April 22-23 in Cambridge, Mass.
